Welcome to the e-CCO Library!

P781: Biological treatment and surgery in IBD patients stratified by age groups
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Svatun Lirhus1*, M. Ekmark2, B. Saeboe2, B. Moum3, H.O. Melberg4,5

Created: Thursday, 21 February 2019, 9:14 AM
P781: Defining the economic burden of venous thromboembolism after surgery for inflammatory bowel disease in the USA: a national inpatient sample study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. H. A. Lee1, A. Aiello2, L. Stocchi1, J. Lipman1, S. Shawki1, T. Hull1, S. Steele1, S. Holubar*1

Created: Friday, 22 February 2019, 9:41 AM
P781: The stability of the fecal microbiota in Crohn's disease patients with changing disease course
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Tedjo D.1,2, Savelkoul P.2, Masclee A.1, Bodelier A.1, Pierik M.1, Penders J.2, Jonkers D.*1

Created: Wednesday, 20 February 2019, 10:36 AM
P781: Treatment outcome of tofacitinib dose reduction to 5 mg BID vs remaining on 10 mg BID in patients with Ulcerative Colitis who were in stable remission on 10 mg BID: Updated 30-month data from the double-blind, randomised RIVETING study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rubin, D.T.(1);Panés, J.(2);Torres, J.(3,4,5);Kobayashi, T.(6);Su, C.(7);Lawendy, N.(7);Modesto, I.(8);Segovia, M.(7,9);Gardiner, S.(8);Wang, W.(7);Vermeire, S.(10)*;
Created: Friday, 14 July 2023, 11:12 AM
P782 Immune status to viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

H.S. Hong1, J. Jung2, S.H. Park3, S.M. Noh4, E.H. Oh4, J.Y. Kim4, J. Kim4, S.W. Hwang3, D.H. Yang4, J.S. Byeon4, S.J. Myung4, S.K. Yang3, B.D. Ye3

Created: Thursday, 30 January 2020, 10:12 AM
P782: A new compatibility test for donor selection for faecal microbiota transplantation in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ponce-Alonso M.1, Garcia-Fernandez S.1, Aguilera L.2, Rodriguez-de-Santiago E.2, Foruny J.R.2, Roy G.3, DelCampo R.1, Canton R.1, Lopez-Sanroman A.*2

Created: Wednesday, 20 February 2019, 10:36 AM
P782: Living with ulcerative colitis in Germany: quantifying the healthcare resource utilisation and direct healthcare costs associated with the treatment of moderate to severe ulcerative colitis in Germany
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Dignass*1, J. Waller2, J. C. Cappelleri3, L. Salese4, A. Kisser5, L. Dietz5, M. DiBonaventura6, R. Wood2, D. Bargo6

Created: Friday, 22 February 2019, 9:41 AM
P782: Natural history of acute severe ulcerative colitis in elderly: A population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Bril1*, A. Leroyer2, M. Fumery3, C. Charpentier1, B. Pariente2, H. Sarter2, D. Laharie4, C. Gower-rousseau2, G. Savoye1

Created: Thursday, 21 February 2019, 9:14 AM
P782: Ustekinumab in Ulcerative colitis: a real-life effectiveness study across multiple Belgian centers (SULTAN)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Holvoet, T.(1)*;Truyens, M.(2);Reenaers, C.(3);Baert, F.(4);Vandenbranden, S.(5);Cremer, A.(6);Pouillon, L.(7);Dewint, P.(8);Van Moerkercke, W.(9);Rahier, J.F.(10);Vandermeulen, L.(11);Van Dongen, J.(12);Peeters, H.(13);Lambrecht, G.(14);Vijverman, A.(15);Lobaton, T.(16);
Created: Friday, 14 July 2023, 11:12 AM
P783 Non-alcoholic fatty liver disease and advanced liver disease in patients with inflammatory bowel disease: prevalence and risk factors
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Demir

Created: Thursday, 30 January 2020, 10:12 AM
P783: Ciprofloxacin resistance in ESBL producing enterobacteriaceae colonizing the gut in IBD patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Skuja V.*1,2, Pekarska K.3, Straume Z.2,4, Rudzīte D.5, Lavrinoviča E.5, Piekuse L.6, Dauvarte H.3, Vašuka E.1,7, Dobelniece L.1,7, Zalizko P.4,8, Derovs A.2,9, Krūmiņa A.10,11, Lejnieks A.1,7

Created: Wednesday, 20 February 2019, 10:36 AM
P783: Increased risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide population-based study
Year: 2018
Source: ECCO '18 Vienna
Authors:

E.A. Kang1*, J. Lee1, K. Han2, J. Kim1, J. Chun1, J.S. Kim1, J.P. Im1

Created: Thursday, 21 February 2019, 9:14 AM
P783: Long-term colectomy rate in acute severe ulcerative colitis. An observational multi-centre study on behalf of IG-IBD (Italian group for the study of inflammatory bowel disease)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Festa*1, M. L. Scribano2, D. Pugliese3, E. Sarli4, C. Bezzio5, M. B. Principi6, D. G. Ribaldone7, M. Allocca8, G. Mocci9, G. Bodini10, R. Spagnuolo11, P. Vernia12, S. Mazzuoli13, G. Laino14, B. Barberio15, G. Zerboni16, A. Aratari16, C. Papi16

Created: Friday, 22 February 2019, 9:41 AM
P783: Symptom Improvement of ulceRative colitis after an Injection dose of Ustekinumab in Japanese clinical practice, measured using patient-reported outcomes (SIRIUS) study, Interim Analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Matsuoka, K.(1)*;Katsumasa, N.(2);Murata, Y.(2);Hisamatsu, T.(3);
Created: Friday, 14 July 2023, 11:12 AM
P784 A new questionnaire to investigate patients’ knowledge of relevant aspects of inflammatory bowel disease clinical course and outcomes: preliminary results
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Zerboni1, S. Barello2, S. Festa3, A. Aratari3, G. Graffigna2, C. Papi3

Created: Thursday, 30 January 2020, 10:12 AM
P784: A comparison study of the mucosa-associated microbiota between inflamed and non-inflamed sites in ulcerative colitis patients
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hirano A.*1, Umeno J.1, Shibata H.2, Kitazono T.1, Esaki M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P784: Prevalence of cervical dysplasia in women with inflammatory bowel disease: data from the Parelsnoer Institute (PSI) and PALGA database (PAP-IBD study)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Goetgebuer*1, J. Kreijne1, C. Aitken2, M. Pierik3, F. Hoentjen4, N. de Boer5, B. Oldenburg6, A. van der Meulen7, C. Ponsioen8, G. Dijkstra9, F. van Kemenade10, G. Nieuwenhuyzen – de Boer11, A. Siebers12, C. J. van der Woude1, A. de Vries1

Created: Friday, 22 February 2019, 9:41 AM
P784: Real-world use and 6-month effectiveness of vedolizumab subcutaneous in IBD patients: results of the VEDO-IBD study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Plachta-Danielzik, S.(1);Bokemeyer, B.(1,2,3)*;Efken, P.(4);Mohl, W.(5);Hoffstadt, M.(6);Krause, T.(7);Schweitzer, A.(8);Schnoy, E.(9);Ehehalt, R.(10);Trentmann, L.(11);Teich, N.(12);Atreya, R.(13);Franzenburg, S.(1);Hartmann, P.(4);Wenske, T.(1);Schreiber, S.(1,3);
Created: Friday, 14 July 2023, 11:12 AM
P784: The direct healthcare costs of Crohn’s disease increased over the last two decades in a Dutch population-based cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Lalisang1*, D. Wintjens1,2, M. Romberg-Camps3, A. van Bodegraven3, L. Oostenbrug3, J. Haans1, A. Masclee1,2, D. Jonkers1,2, M. Pierik1,2

Created: Thursday, 21 February 2019, 9:14 AM
P785 Predictors of mortality in IBD patients treated for pneumonia
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. Ukashi1,2, Y. Barash2,3,4, M.J. Segel2,5, B. Ungar1,2, S. Soffer2,3,4, S. Ben-Horin1,2, E. Klang2,3,4, U. Kopylov1,2

Created: Thursday, 30 January 2020, 10:12 AM